[go: up one dir, main page]

GB201803787D0 - Oncolytic viruses as adjuvants - Google Patents

Oncolytic viruses as adjuvants

Info

Publication number
GB201803787D0
GB201803787D0 GBGB1803787.9A GB201803787A GB201803787D0 GB 201803787 D0 GB201803787 D0 GB 201803787D0 GB 201803787 A GB201803787 A GB 201803787A GB 201803787 D0 GB201803787 D0 GB 201803787D0
Authority
GB
United Kingdom
Prior art keywords
adjuvants
oncolytic viruses
oncolytic
viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1803787.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bourgeois Daigneault Marie Claude
Original Assignee
Bourgeois Daigneault Marie Claude
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bourgeois Daigneault Marie Claude filed Critical Bourgeois Daigneault Marie Claude
Publication of GB201803787D0 publication Critical patent/GB201803787D0/en
Ceased legal-status Critical Current

Links

GBGB1803787.9A 2018-02-22 2018-03-09 Oncolytic viruses as adjuvants Ceased GB201803787D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862633883P 2018-02-22 2018-02-22

Publications (1)

Publication Number Publication Date
GB201803787D0 true GB201803787D0 (en) 2018-04-25

Family

ID=61972904

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1803787.9A Ceased GB201803787D0 (en) 2018-02-22 2018-03-09 Oncolytic viruses as adjuvants

Country Status (1)

Country Link
GB (1) GB201803787D0 (en)

Similar Documents

Publication Publication Date Title
IL282985B (en) Oncolytic virus modifications
IL267949A (en) Altered virus
PL3659614T3 (en) Oncolytic vaccinia virus
ZA202005848B (en) Modified oncolytic adenoviruses
IL263550A (en) Vaccine against infectious bronchitis virus
SG11202009854XA (en) Modified viral capsids
IL267785A (en) Virus
GB201616007D0 (en) Novel Adjuvants
GB201910794D0 (en) Vaccine
GB201611512D0 (en) Fish virus
EP3624825A4 (en) RECOMBINANT ONCOLYTIC VIRUS
GB201820983D0 (en) Virus
GB201702193D0 (en) Hepatitis E virus vaccine
GB201803787D0 (en) Oncolytic viruses as adjuvants
GB201911636D0 (en) Vaccine
HK40044293A (en) Oncolytic viruses as adjuvants
GB201811382D0 (en) Vaccine
ZA201608436B (en) Live attenuated african horsesickness virus
GB201916292D0 (en) Viruses
HK40041691A (en) Treatment using oncolytic virus
GB201813175D0 (en) Virus use
HK40019139A (en) Oncolytic virus therapy
AU2018903913A0 (en) Virus Vaccine
GB201716047D0 (en) Virus
AU2015904101A0 (en) Genetically stable oncolytic virus

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)